| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.055 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.05 | 0.8 |